Find your path to Jeff
612 people in our graph share verified history with Jeff — schools, employers, funds. One of them is your warm intro.
Crystal HuangunlockedJeff: together at Harvard University (2007–2009)
×7Jeff: together at Harvard University
Jeff: together at MIT
×2Jeff: together at Constellation Pharma
About
A scientist and biotech entrepreneur with 15+ years in drug discovery, most recently founder and CEO of NeoPhore and previously COO of PhoreMost. He holds a bachelor's from the Harvard Extension School with expertise in cancer and metabolic disease.
Experience
- Neurocentrx Pharma Ltd.Chief Executive Officercurrent2025 — presentLondon Area, United Kingdom
- o2h venturesVenture Partnercurrent2020 — present
- Opal TherapeuticsDirector2021 — 2025
- Stingray Bio LtdInterim CEO2021 — 2025United Kingdom
- UK BiocentreVolunteer (UK Lighthouse COVID testing labs)2020 — 2021Milton Keynes, England, United Kingdom
- NeoPhore LtdCEO2018 — 2020Greater Cambridge Area
- PhoreMost LtdCOO2015 — 2018Cambridge, United Kingdom
- BioMed Valley DiscoveriesAssociate2010 — 2015
- Constellation PharmaceuticalsSenior Associate2008 — 2010
- NovartisAssociate2005 — 2008
- MITTechnician2003 — 2005
- National Cancer InstituteIntern2001 — 2002
- The Jackson LaboratoryIntern1997 — 2001
Skills & more
StrategyStrategic PlanningManagementLeadershipBiotechnology17Cell Biology10Life Sciences11Drug DevelopmentEntrepreneurshipOncologyStart-upsCorporate Development
+12 more
Due DiligenceTechnology TransferMolecular BiologyBiochemistryMicroscopyDrug DiscoveryClinical DevelopmentCell CultureCancerLicensingPatentsBiopharmaceuticalsFrom Jeff's professional profile.
Colleagues at O2h Ventures
Ajit Singh Guller
Marketing Manager at O2h Ventures
Andy Morley
Principal at O2h Ventures
Catherine Beech
Independent Representative to the Investment Advisory Panel at O2h Ventures
Catherine Stace
VP - Strategic Relationships at O2h Ventures
Cengiz Tarhan
Independent Representative of the Investment Advisory Panel at O2h Ventures
Chris Reid
Venture Partner at O2h Ventures
Chris White
Vice President, Business Development at O2h Ventures
Dr Chris Torrance
Independent Representative of the Investment Advisory Panel at O2h Ventures
Frequently asked questions
- Who is Jeff Roix?
- A scientist and biotech entrepreneur with 15+ years in drug discovery, most recently founder and CEO of NeoPhore and previously COO of PhoreMost. He holds a bachelor's from the Harvard Extension School with expertise in cancer and metabolic disease.
- Where does Jeff Roix work?
- Jeff Roix is Venture Partner at O2h Ventures.
- Where did Jeff Roix go to school?
- Jeff Roix studied at Harvard University (ALB, Extension School, Biology).
Same school
Also attended Harvard University2,000
Ron ConwayFounder of SV AngelAlfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalG
+ 1,994 more
Shared employers
Also worked at Opal Therapeutics1
Also worked at PhoreMost Ltd6
Jonathan MilnerInvestor at Cambridge Innovation CapitalSatoshi KonagaiInvestment Lead at Astellas Venture Management LLCPierre SochaPartner at Amadeus Capital PartnersAlastair KilgourFounder at Parkwalk AdvisorsDr Chris TorranceIndependent Representative of the Investment Advisory Panel at O2h VenturesPierre SochaGeneral Partner at Amadeus Technology
Also worked at Novartis201
Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures
+ 195 more
